These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2219389)
1. Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content. Tyerman K; Barron PT; Da Costa M; McCleish M; Fulford A; Collier SJ; Thiru S Transplant Proc; 1990 Oct; 22(5):2325. PubMed ID: 2219389 [No Abstract] [Full Text] [Related]
2. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts. Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818 [No Abstract] [Full Text] [Related]
3. Endothelial target cell-dependent, differing patterns of chronic vascular renal allograft rejection in the rat. van Breda Vriesman JC; Vlek LF; Duistermaat E; Duijvestijn AM Transplant Proc; 1990 Dec; 22(6):2519-21. PubMed ID: 2264132 [No Abstract] [Full Text] [Related]
4. Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat. Romaniuk A; Ryffa T; Rowiński W; Olszewski WL Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):253-60. PubMed ID: 2639625 [TBL] [Abstract][Full Text] [Related]
5. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Buonocore S; Flamand V; Goldman M; Braun MY Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166 [TBL] [Abstract][Full Text] [Related]
8. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts. Klempnauer J; Steiniger B Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182 [No Abstract] [Full Text] [Related]
9. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival. DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121 [TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells. Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544 [No Abstract] [Full Text] [Related]
11. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival. Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163 [No Abstract] [Full Text] [Related]
12. The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine. Yacoub M; Festenstein H; Doyle P; Martin M; McCloskey D; Awad J; Gamba A; Khaghani A; Holmes J Transplant Proc; 1987 Feb; 19(1 Pt 3):2487-9. PubMed ID: 3274543 [No Abstract] [Full Text] [Related]
13. Prolonged rat heart allograft survival and reduced graft immunogenicity after photochemical donor and transplant pretreatment. Oesterwitz H; Eichler C; Schneider W; Kaden J Z Versuchstierkd; 1989; 32(2):77-82. PubMed ID: 2667272 [TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for an effect of donor irradiation on liver allograft rejection. Yokoi Y; Nakamura S; Suzuki S; Baba S; Naji A; Amemiya H; Kimura H Transplant Proc; 1996 Jun; 28(3):1725-6. PubMed ID: 8658857 [No Abstract] [Full Text] [Related]
15. Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells. Choti M; Lenrow D; Roza A; Markmann J; Naji A Transplant Proc; 1989 Feb; 21(1 Pt 1):478-9. PubMed ID: 2565055 [No Abstract] [Full Text] [Related]
16. Donor pretreatment prolongs survival of discordant xenografts. Jefferson KP; Tyerman KS; McLeish M; Collier DS; Thiru S Transplant Proc; 1991 Aug; 23(4):2280-1. PubMed ID: 1871871 [No Abstract] [Full Text] [Related]
17. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells. Chen T; Xu H; Wang HQ; Zhao Y; Zhu CF; Zhang YH; Ji MJ; Hua YB; Wu WX Transplant Proc; 2008 Dec; 40(10):3711-3. PubMed ID: 19100471 [TBL] [Abstract][Full Text] [Related]
18. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected. Jaskłowska-Englisz M; Olszewski WL Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224 [No Abstract] [Full Text] [Related]
19. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival. Sone Y; Sakagami K; Orita K Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831 [No Abstract] [Full Text] [Related]
20. Modified graft rejection by transfusion of the donor: a role for dendritic cells. Heineman E; Bouwman E; Marquet RL; Jeekel J Transplant Proc; 1987 Feb; 19(1 Pt 2):1470-2. PubMed ID: 3274358 [No Abstract] [Full Text] [Related] [Next] [New Search]